These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25145312)

  • 1. Medical cost impact of intrathecal baclofen therapy for severe spasticity.
    Saulino M; Guillemette S; Leier J; Hinnenthal J
    Neuromodulation; 2015 Feb; 18(2):141-9; discussion 149. PubMed ID: 25145312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
    Nelson MES; McGuire JR
    Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
    de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
    J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of intrathecal baclofen therapy in Japan.
    Hattori N; Hirayama T; Katayama Y
    Neurol Med Chir (Tokyo); 2012; 52(7):482-7. PubMed ID: 22850496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
    Turner M; Nguyen HS; Cohen-Gadol AA
    J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
    Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
    Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Intrathecal Baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective.
    Vidal J; Slof J; Serrano D; Marqués T; Kumru H; Benito-Penalva J
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):67-76. PubMed ID: 27142176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive experience with intrathecal baclofen treatment in children with severe cerebral palsy.
    Overgård TM; Kjærsgaard-Hansen L; Søe M; Illum NO
    Dan Med J; 2015 Jan; 62(1):A4999. PubMed ID: 25557334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
    Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
    PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database.
    Narendran RC; Duarte RV; Valyi A; Eldabe S
    BMJ Open; 2015 Jun; 5(6):e007517. PubMed ID: 26129634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes, complications, and dosing of intrathecal baclofen in the treatment of multiple sclerosis: a systematic review.
    Cozzi FM; Zuckerman D; Sacknovitz A; Gozum N; Syal A; Danisi F; Sukul V
    Neurosurg Focus; 2024 Jun; 56(6):E14. PubMed ID: 38823049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
    Borowski A; Pruszczyński B; Miller F; Synder M
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
    Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
    Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury.
    Yoon YK; Lee KC; Cho HE; Chae M; Chang JW; Chang WS; Cho SR
    Medicine (Baltimore); 2017 Aug; 96(34):e7472. PubMed ID: 28834868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.
    Pin TW; McCartney L; Lewis J; Waugh MC
    Dev Med Child Neurol; 2011 Oct; 53(10):885-95. PubMed ID: 21635230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.